126P The HLA I composite score and VHIO immune gene-expression signature (VIGex) as selection tools to explore the tumor microenvironment (TME) in patients (pts) treated with immunotherapy (IT)

Autor: Saavedra Santa Gadea, O., Vila Casadesus, M., Mirallas, O., Calvo, A.H., Ros Montana, F.J., Baraibar Argota, I., Suarez Rodriguez, C., Oberoi, A., Morales Barrera, R., Iranzo Gomez, P., Alonso, G., Brana, I., Cabrera Navarro, A., Hernández-Illán, E., Vieito Villar, M., Elez Fernandez, M.E., Gonzalez Rodriguez, M., Felip, E., Garralda, E., Vivancos, A.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S595-S595
Databáze: ScienceDirect